Asymmetric septal hypertrophy – a marker of hypertension in aortic stenosis (a SEAS substudy)

References

• Maron BJ, Edwards JE, Epstein SE. Disproportionate ventricular thickening in patients with systemic hypertension. Chest. 1978;73:466–470.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Zampi I, Schillaci G, Gatteschi C, Battistelli M, . Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. Am J Cardiol. 1994;73:247–252.
   PubMed Web of Science ®Google Scholar
• Safar ME, Lehner JP, Vincent MI, Plainfosse MT, Simon AC. Echocardiographic dimensions in borderline and sustained hypertension. Am J Cardiol. 1979;44:930–935.
   PubMed Web of Science ®Google Scholar
• Safar M, Benessiano JR, Hornysk AL. Asymmetric septal hypertrophy and borderline hypertension. Int J Cardiol. 1982; 2:103–108.
   PubMed Web of Science ®Google Scholar
• Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, . Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634.
   PubMed Web of Science ®Google Scholar
• Haering JM, Communale ME, Parker RA, Lowenstein E, Douglas PS. Krumholz HM, . Cardiac risk of noncardiac surgery in patients with assymetric septal hypertrophy. Anesthesiology. 1996;85:254–259.
   PubMed Web of Science ®Google Scholar
• Mehta RH, Bruckman D, Dar S, Tsai T, Russman P, Karavite D, . Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg. 2001;122:919–928.
   PubMed Web of Science ®Google Scholar
• Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, . Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol. 2007;99:970–973.
   PubMed Web of Science ®Google Scholar
• Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, . Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–1356.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, . Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, . Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, . Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Raj MV, Srinivas V, Graham IM, Evans DW. Coexistence of asymmetric septal hypertrophy and aortic valve disease in adults. Thorax. 1979;34:91–95.
   PubMed Web of Science ®Google Scholar
• Dunn FG, Chandraratna P, deCarvalho JG, Basta LL, Frohlich ED. Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol. 1977; 39:789–795.
   PubMed Web of Science ®Google Scholar
• Wicker P, Roudaut R, Haissaguere M, Villega-Arino P, Clementy J, Dallocchio M, Prevalence and significance of asymmetric septal hypertrophy in hypertension: An echocardiographic and clinical study. Eur Heart J. 1983;4 Suppl G:1–5
   PubMed Web of Science ®Google Scholar
• Niederle P, Widimsky J, Jandova R, Ressl J, Grospic A. Echocardiographic assessment of the left ventricle in juvenile hypertension. Int J Cardiol. 1982;2:91–101.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, . Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007;49:311–316.
   PubMed Web of Science ®Google Scholar
• Dalsgaard M, Egstrup K, Wachtell K, Gerdts E, Cramariuc D, Kjaergaard J, Hassager C. Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). Am J Cardiol. 2008;1;101: 1030–103425.
   Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med. 1989;110:101–107.
   PubMed Web of Science ®Google Scholar
• Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, . Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290–3295.
   PubMed Web of Science ®Google Scholar
• Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E. J Hypertens. 2010;28:377–383.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, . Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy). Am J Cardiol. 2008;15;101:510–515.
   Google Scholar
• Li JK, Zhu JY, Nanna M. Computer modeling of the effects of aortic valve stenosis and arterial system afterload on left ventricular hypertrophy. Comput Biol Med.1997;27:477–485.
   PubMed Web of Science ®Google Scholar
• Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, . Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study (SHS). Am Heart J. 2006;151:412–418.
   PubMed Web of Science ®Google Scholar
• Lund O, Flø C, Jensen FT, Emmertsen K, Nielsen TT, Rasmussen BS, . Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J. 1997;18:1977–198726.
   PubMed Web of Science ®Google Scholar
• . 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsBonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, .; 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. Circulation. 2008;118:523–661.
   Google Scholar